Suppression of the tumorigenicity of human hepatoma hep3B cells by long-term retinoic acid treatment
- 19 January 1996
- journal article
- Published by Elsevier in Cancer Letters
- Vol. 99 (1), 79-85
- https://doi.org/10.1016/0304-3835(95)04040-4
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Vitamin A ReceptorsNutrition Reviews, 2009
- Vitamin A in Epithelial Differentiation and Skin CarcinogenesisPublished by Oxford University Press (OUP) ,2009
- Transcriptional regulation of transferrin and albumin genes by retinoic acid in human hepatoma cell line Hep3BBiochemical Journal, 1992
- The PML-RARα fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RARCell, 1991
- Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RARα with a novel putative transcription factor, PMLCell, 1991
- The t(15;17) translocation of acute promyelocytic leukaemia fuses the retinoic acid receptor α gene to a novel transcribed locusNature, 1990
- Identification of a retinoic acid responsive element in the retinoic acid receptor & beta;geneNature, 1990
- Hepatitis B virus DNA integration in a sequence homologous to v-erb-A and steroid receptor genes in a hepatocellular carcinomaNature, 1986
- Human Hepatocellular Carcinoma Cell Lines Secrete the Major Plasma Proteins and Hepatitis B Surface AntigenScience, 1980
- A vitamin A analogue inhibits radiation-induced oncogenic transformationNature, 1978